Gregory J Withbroe

Title: Gregory J Withbroe: Innovator in Glycogen Phosphorylase Inhibitors

Introduction

Gregory J Withbroe is a notable inventor based in Gales Ferry, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of glycogen phosphorylase inhibitors. With a total of 2 patents, his work has implications for treating various metabolic diseases.

Latest Patents

One of his latest patents focuses on "Processes and intermediates for preparing glycogen phosphorylase inhibitors." This invention provides novel processes and intermediates useful in the preparation of certain N-(indole-2-carbonyl)-β-alaninamide compounds. These compounds are glycogen phosphorylase inhibitors that can be beneficial in treating diseases such as hypercholesterolemia, hyperglycemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis, diabetes, diabetic cardiomyopathy, infection, tissue ischemia, myocardial ischemia, and in inhibiting tumor growth. Another significant patent involves "Methods for preparing sodium-hydrogen exchanger type-1 inhibitors," which further showcases his innovative approach to pharmaceutical development.

Career Highlights

Gregory J Withbroe is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to groundbreaking research and development in the field of drug discovery and therapeutic solutions.

Collaborations

Throughout his career, Gregory has collaborated with esteemed colleagues such as Frank R Busch and Mark T Barrila. These collaborations have enhanced the scope and impact of his research, leading to advancements in the pharmaceutical industry.

Conclusion

Gregory J Withbroe stands out as an influential inventor in the realm of glycogen phosphorylase inhibitors. His innovative patents and contributions to Pfizer Corporation highlight his commitment to advancing medical science and improving patient outcomes.